Carl Philipp Zinner

Carl Philipp Zinner

Auto-generated profile, based on publicly available information

Carl Philipp Zinner

Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel 2 , 4031 Basel

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Science Advances
Verified
Journal Article
Open access
TSTala Shekarian
Tala Shekarian
CZCarl P. Zinner
Carl P. Zinner
EBEwelina M. Bartoszek
Ewelina M. Bartoszek
WDWandrille Duchemin
Wandrille Duchemin
AWAnna T. Wachnowicz
Anna T. Wachnowicz
GHGregor Hutter
Gregor Hutter
A patient-tailored, ex vivo drug response platform for glioblastoma (GBM) would facilitate therapy planning, provide insights into treatment-induced mechanisms in the immune tumor microenvironment (iTME), and enable the discovery of biomarkers of response. We cultured regionally annotated GBM explants in perfusion bioreactors to assess iTME responses to immunotherapy. Explants were treated with anti-CD47, anti–PD-1, or their combination, and analyzed by multiplexed microscopy [CO-Detection by indEXing (CODEX)], enabling the spatially resolved identification of >850,000 single cells, accompanied by explant secretome interrogation. Center and periphery explants differed in their cell type and soluble factor composition, and responses to immunotherapy. A subset of explants displayed increased interferon-γ levels, which correlated with shifts in immune cell composition within specified tissue compartments. Our study demonstrates that ex vivo immunotherapy of GBM explants enables an active antitumoral immune response within the tumor center and provides a framework for multidimensional personalized assessment of tumor response to immunotherapy.

20 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JFJennifer A. Fitzgerald
Jennifer A. Fitzgerald
KKKrishna Tulasi Kirla
Krishna Tulasi Kirla
CZCarl P. Zinner
Carl P. Zinner
CBColette M. Vom Berg
Colette M. Vom Berg
The analysis of larval zebrafish locomotor behavior has emerged as a powerful indicator of perturbations in the nervous system and is used in many fields of research, including neuroscience, toxicology and drug discovery. The behavior of larval zebrafish however, is highly variable, resulting in the use of large numbers of animals and the inability to detect small effects. In this study, we analyzed whether individual locomotor behavior is stable over development and whether behavioral parameters correlate with physiological and morphological features, with the aim of better understanding the variability and predictability of larval locomotor behavior. Our results reveal that locomotor activity of an individual larva remains consistent throughout a given day and is predictable throughout larval development, especially during dark phases, under which larvae demonstrate light-searching behaviors and increased activity. The larvae’s response to startle-stimuli was found to be unpredictable, with no correlation found between response strength and locomotor activity. Furthermore, locomotor activity was not associated with physiological or morphological features of a larva (resting heart rate, body length, size of the swim bladder). Overall, our findings highlight the areas of intra-individual consistency, which could be used to improve the sensitivity of assays using zebrafish locomotor activity as an endpoint.

7 June 2023 in Journal of Hepatology
Verified
Journal Article
Open access
SUSarp Uzun
Sarp Uzun
CZCarl P. Zinner
Carl P. Zinner
ABAmke C. Beenen
Amke C. Beenen
IAIlaria Alborelli
Ilaria Alborelli
EBEwelina M. Bartoszek
Ewelina M. Bartoszek
MMMatthias Matter
Matthias Matter
Liver injury after COVID-19 vaccination is very rare and shows clinical and histomorphological similarities with autoimmune hepatitis (AIH). Little is known about the pathophysiology of COVID-19 vaccine-induced liver injury (VILI) and its relationship to AIH. Therefore, we compared VILI with AIH. Formalin-fixed and paraffin-embedded liver biopsy samples from patients with VILI (n=6) and from patients with an initial diagnosis of AIH (n=9) were included. Both cohorts were compared by histomorphological evaluation, whole-transcriptome and spatial transcriptome sequencing, multiplex immunofluorescence and immune repertoire sequencing. Histomorphology was similar in both cohorts but showed more pronounced centrilobular necrosis in VILI. Gene expression profiling showed that mitochondrial metabolism and oxidative stress-related pathways were more and interferon response pathways less enriched in VILI. Multiplex analysis revealed that inflammation in VILI was dominated by CD8+ effector T cells, similar to drug-induced autoimmune like hepatitis (DI-AILH). In contrast, AIH showed a dominance of CD4+ effector T cells and CD79a+ B and plasma cells. T-cell receptor (TCR) and B-cell receptor (BCR) sequencing showed that T- and B-cell clones were more dominant in VILI than in AIH. In addition, many T-cell clones detected in the liver were also found in the blood. Interestingly, analysis of TCR beta chain and Ig heavy chain variable-joining gene usage further showed that TRBV6-1, TRBV5-1, TRBV7-6 and IgHV1-24 genes are used differently in VILI than in AIH. Our analyses support that SARS-CoV-2 vaccination-induced liver injury is related to AIH but also shows distinct differences from AIH in histomorphology, pathway activation, cellular immune infiltrates, and TCR usage. VILI may be a separate entity, which is distinct from AIH and more closely related to DI-AILH. Little is known about the pathophysiology of COVID-19 vaccine-induced liver injury. Our analysis shows that COVID-19 vaccine-induced liver injury shares some similarities with autoimmune hepatitis, but also has distinct differences such as increased activation of metabolic pathways, a more prominent CD8+ T cell infiltrate, and an oligoclonal T and B cell response. Our findings suggest that vaccine-induced liver injury is a distinct disease entity. Therefore, there is a good chance that many patients with COVID-19 vaccine-induced liver injury will recover completely and do not develop long-term autoimmune hepatitis.

11 October 2018 in Journal of Non-Equilibrium Thermodynamics
Verified
Journal Article
Closed access
PDF file
CZCarl Philipp Zinner
Carl Philipp Zinner
HÖHans Christian Öttinger
Hans Christian Öttinger
The shock structures of a 13 moment generalized hydrodynamics system of rarefied gases are simulated. These are first order hyperbolic equations derived from the Boltzmann equation. The investigated moment system stands out due to having an entropy evolution. In addition, a particular interest arises from the fact that the equations not only contain nonconservative products, but also provide the key to solving this mathematical and numerical issue by means of a simple substitution utilizing the physical entropy evolution. The apparent success of this method warrants investigation and provides a new perspective and starting point for finding general approaches to nonconservative products and irreversible processes. Furthermore, the system shows physically accurate results for low Mach numbers and is able to reveal the nonequilibrium entropy profile across a shock wave.

22 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMichal Beffinger
Michal Beffinger
LSLinda Schellhammer
Linda Schellhammer
BTBetül Taskoparan
Betül Taskoparan
SDSereina Deplazes
Sereina Deplazes
USUlisse Salazar
Ulisse Salazar
JBJohannes vom Berg
Johannes vom Berg
Glioblastoma remains a challenging indication for immunotherapy: the blood-brain barrier hampers accessibility for systemic treatments and the immunosuppressive microenvironment impedes immune attack. Intratumoral therapy with the proinflammatory cytokine interleukin-12 (IL-12) can revert immunosuppression but leakage into the circulation causes treatment-limiting toxicity. Here we engineer an IL-12Fc fusion cytokine with reduced binding to the neonatal Fc receptor FcRn. FcRn-silenced IL-12Fc avoids FcRn-mediated brain export, thus exhibits prolonged brain retention and reduced blood levels, which prevents toxicity. In murine glioblastoma, FcRn-silenced IL-12Fc induces more durable responses with negligible systemic cytokine exposure and boosts the efficacy of radio- and chemotherapy. It triggers anti-tumor responses independently of peripheral T cell influx or lymphopenia and leads to inflammatory polarization of the tumor microenvironment in patient-derived glioblastoma explants. FcRn-silencing of IL-12Fc may unlock the full potential of IL-12 for brain cancer therapy and could be further applied to containing the activity of other therapeutics targeting neurological diseases.

1 February 2019 in Physics of Fluids
Verified
Journal Article
Open access
PDF file
CZCarl Philipp Zinner
Carl Philipp Zinner
HÖHans Christian Öttinger
Hans Christian Öttinger
One of the major challenges in extending hydrodynamics to far from equilibrium gas flows comes with the need of new boundary conditions for any new modeling approach. The difficulty lies in finding an accurate set of physical conditions at the boundary which simultaneously form a well-posed system of equations. In this paper, we study a system of moment equations for rarefied gas flows that comes equipped with an entropy. This allows a straightforward derivation of boundary conditions which are consistent with the mathematical requirements of the system. The complete nonlinear system is simulated in a rarefied channel flow setting and compared to standard approaches. The results exhibit most of the desired rarefaction effects, such as temperature jump and velocity slip at the wall.